Answers are grounded in this paper and cite their sources.
Background: R561H being the first reported in Rwanda in 2014, but limited sampling left questions about its early distribution and origin. Methods: prevalence, as determined by rapid testing or microscopy done during the DHS study (n clusters = 67, n samples = 1873). Results: We detected 476 parasitemias among 1873 residual blood spots from a 2014-2015 Rwanda Demographic Health Survey. We sequenced 351 samples: 341/351 were wild-type (97.03% weighted), and 4 samples (1.34% weighted) harbored R561H that were significantly spatially clustered. Other nonsynonymous mutations found were V555A (3), C532W (1), and G533A (1). Conclusions: Our study better defines the early distribution of R561H in Rwanda. Previous studies only observed the mutation in Masaka as of 2014, but our study indicates its presence in higher-transmission regions in the southeast of the country at that time.
No takes yet. Share an insight, caveat, or question.
Kirby et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: